Comprehensive RNA involved in Cell Death Pathways research database with advanced search and filtering capabilities
| RNA Name | Mechanism of Action | Effect on Cancer | Reference |
|---|---|---|---|
|
miR-374c-5p
miRNA |
Not reported | Tumor suppressor: downregulated in BC; overexpression inhibits proliferation, migration and EMT, and induces apoptosis (via TAF7/DEPDC1) | PMID: 31162714 |
External Database SearchDetailed Information
RNA Name:
miR-374c-5p
Mechanism of Action:
Not reported
Effect on Cancer:
Tumor suppressor: downregulated in BC; overexpression inhibits proliferation, migration and EMT, and induces apoptosis (via TAF7/DEPDC1)
PMID:
31162714
|
|||
|
TFRC
mRNA |
Transferrin receptor?1 imports iron and increases labile Fe2+, sensitizing to ferroptosis. | ER?negative/TNBC cells with higher TFRC show greater sensitivity to sulfasalazine?induced ferroptosis. | PMID: 31173262 |
External Database SearchDetailed Information
RNA Name:
TFRC
Mechanism of Action:
Transferrin receptor?1 imports iron and increases labile Fe2+, sensitizing to ferroptosis.
Effect on Cancer:
ER?negative/TNBC cells with higher TFRC show greater sensitivity to sulfasalazine?induced ferroptosis.
PMID:
31173262
|
|||
|
IFNG
mRNA |
IFN??/JAK?STAT�IRF1 axis transcriptionally activates ALOX15B, enhancing lipid peroxidation and ferroptosis sensitivity in TNBC cells. | Sensitizes TNBC cells to ferroptosis; tumor?suppressive. | PMID: 33495298 |
External Database SearchDetailed Information
RNA Name:
IFNG
Mechanism of Action:
IFN??/JAK?STAT�IRF1 axis transcriptionally activates ALOX15B, enhancing lipid peroxidation and ferroptosis sensitivity in TNBC cells.
Effect on Cancer:
Sensitizes TNBC cells to ferroptosis; tumor?suppressive.
PMID:
33495298
|
|||
|
GSK3B
mRNA |
Positive modulator of ferroptosis; active GSK3? disrupts iron homeostasis (affects DMT1/FTH1/FTL) to increase labile iron and ferroptosis sensitivity. | In PTEN?KO MDA?MB?231 (TNBC) cells, increased pGSK3?Ser9 (inactive) associates with higher NRF2/xCT and resistance to ferroptosis; implies active GSK3? enhances sensitivity. | PMID: 34732689 |
External Database SearchDetailed Information
RNA Name:
GSK3B
Mechanism of Action:
Positive modulator of ferroptosis; active GSK3? disrupts iron homeostasis (affects DMT1/FTH1/FTL) to increase labile iron and ferroptosis sensitivity.
Effect on Cancer:
In PTEN?KO MDA?MB?231 (TNBC) cells, increased pGSK3?Ser9 (inactive) associates with higher NRF2/xCT and resistance to ferroptosis; implies active GSK3? enhances sensitivity.
PMID:
34732689
|
|||
|
TGFB1
mRNA |
Part of IL?6?TGF??1?HLF axis from TAMs; HLF upregulates GGT1 to boost GSH, conferring ferroptosis resistance. | Promotes ferroptosis resistance and malignant progression in TNBC via TAM?derived IL?6/TGF??1 signaling. | PMID: 34991659 |
External Database SearchDetailed Information
RNA Name:
TGFB1
Mechanism of Action:
Part of IL?6?TGF??1?HLF axis from TAMs; HLF upregulates GGT1 to boost GSH, conferring ferroptosis resistance.
Effect on Cancer:
Promotes ferroptosis resistance and malignant progression in TNBC via TAM?derived IL?6/TGF??1 signaling.
PMID:
34991659
|
|||
|
IL6
mRNA |
TNBC?secreted IL?6 activates TAMs to secrete TGF??1 ? activates HLF in tumor cells ? upregulates GGT1 ? suppresses ferroptosis. | Confers ferroptosis resistance; promotes progression and chemoresistance. | PMID: 34991659 |
External Database SearchDetailed Information
RNA Name:
IL6
Mechanism of Action:
TNBC?secreted IL?6 activates TAMs to secrete TGF??1 ? activates HLF in tumor cells ? upregulates GGT1 ? suppresses ferroptosis.
Effect on Cancer:
Confers ferroptosis resistance; promotes progression and chemoresistance.
PMID:
34991659
|
|||
|
P4HB
mRNA |
Protein disulfide isomerase (encoded by P4HB) is required for erastin-induced ferroptosis in MDA-MB-231 TNBC cells by promoting lipid ROS accumulation. | Facilitates ferroptotic death upon erastin; PDI inhibition reduces ferroptosis in TNBC cells. | PMID: 30367042 |
External Database SearchDetailed Information
RNA Name:
P4HB
Mechanism of Action:
Protein disulfide isomerase (encoded by P4HB) is required for erastin-induced ferroptosis in MDA-MB-231 TNBC cells by promoting lipid ROS accumulation.
Effect on Cancer:
Facilitates ferroptotic death upon erastin; PDI inhibition reduces ferroptosis in TNBC cells.
PMID:
30367042
|
|||
|
HMOX1
mRNA |
HO-1 (HMOX1) axis modulates ferroptosis; HO-1-dependent ferroptosis reported in TNBC cells | HO-1 upregulation can mediate ferroptotic cell death (e.g., HCL-23 triggers HO-1-dependent ferroptosis in TNBC cells) | PMID: 37110625 |
External Database SearchDetailed Information
RNA Name:
HMOX1
Mechanism of Action:
HO-1 (HMOX1) axis modulates ferroptosis; HO-1-dependent ferroptosis reported in TNBC cells
Effect on Cancer:
HO-1 upregulation can mediate ferroptotic cell death (e.g., HCL-23 triggers HO-1-dependent ferroptosis in TNBC cells)
PMID:
37110625
|
|||
|
SIRT3
mRNA |
Drives autophagy?dependent ferroptosis by promoting BECN1?SLC7A11 complex formation (AMPK/mTOR axis). | Enhances ferroptosis and anticancer activity in breast cancer models including TNBC cell lines. | PMID: 37196680 |
External Database SearchDetailed Information
RNA Name:
SIRT3
Mechanism of Action:
Drives autophagy?dependent ferroptosis by promoting BECN1?SLC7A11 complex formation (AMPK/mTOR axis).
Effect on Cancer:
Enhances ferroptosis and anticancer activity in breast cancer models including TNBC cell lines.
PMID:
37196680
|
|||
|
SOCS1
mRNA |
Ferroptosis driver that downregulates GPX4/xCT, elevating lipid peroxidation. | Overexpression induces ferroptosis, inhibits growth and cisplatin resistance in TNBC models. | PMID: 37665951 |
External Database SearchDetailed Information
RNA Name:
SOCS1
Mechanism of Action:
Ferroptosis driver that downregulates GPX4/xCT, elevating lipid peroxidation.
Effect on Cancer:
Overexpression induces ferroptosis, inhibits growth and cisplatin resistance in TNBC models.
PMID:
37665951
|
|||